All stock lists
SAB Biotherapeutics, Inc. (NASDAQ:SABS)
US · Delayed Price · Currency is USD
2.84-0.20 (-6.58%)
Insider Score
––Not scored
SABS Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SABS Stock Insider Trading Activity
SABS stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kropotova Alexandra Other | Tax withheld | 473 | — | — | 1.1% | 41,853 | Sep 17, 2026 | — | Form 4 |
| Kropotova Alexandra Other | Tax withheld | 988 | — | — | 2.3% | 42,308 | Jun 25, 2026 | — | Form 4 |
| Kropotova Alexandra Other | Tax withheld | 988 | — | — | 2.2% | 43,296 | Mar 24, 2026 | — | Form 4 |
| Kropotova Alexandra Other | Tax withheld | 988 | — | — | 2.2% | 44,284 | Dec 11, 2025 | — | Form 4 |
| Moin Andrew Director | Option exercise | 1,740,000 | $1.75 | $3.04M | 380% | 2,198,457 | Sep 29, 2025 | — | Form 4 |
| Sessa Capital GP, LLC Director | Option exercise | 1,740,000 | $1.75 | $3.04M | 380% | 2,198,457 | Sep 29, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.